✦ LIBER ✦

Zevalin radioimmunotherapy offers safe and effective therapy for relapsed or refractory, B cell non-Hodgkin's lymphoma (nhl)

✍ Scribed by M. Saleh; C.A. White; T.E. Witzig; L. Gordon; G.A. Wiseman; C. Emmanouilides; J.L. Murray; J. Lister; R. Landin; P.S. Multani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radioimmunotherapy with 131I-rituximab f

✍ Hye J KANG; Seung S LEE; Kyeong M KIM; Tae H CHOI; Gi J CHEON; Won S KIM; Cheolw 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

External beam radiation therapy after 90

✍ T.E Justice; J.A Martenson; G.A Wiseman; T.E Witzig 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Phase I/II90Y-Zevalin (yttrium-90 ibritu

✍ Gregory A. Wiseman; Christine A. White; Michael Stabin; William L. Dunn; William 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 166 KB

Multicenter phase II study of bendamusti

✍ Ken Ohmachi; Kiyoshi Ando; Michinori Ogura; Toshiki Uchida; Kuniaki Itoh; Nobuko 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

Cladribine combined with rituximab (R-2-

✍ Hirokazu Nagai; Michinori Ogura; Shigeru Kusumoto; Naoto Takahashi; Motoko Yamag 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

The rationale for and background of radi

✍ Mary Beth Riley; Katherine Byar 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 148 KB